Eisai Pharma to set up Global Capability Centre in Visakhapatnam

India Pharma Outlook Team | Thursday, 10 July 2025

 Eisai Pharma

Eisai Pharma, a global leader in human healthcare innovation, has announced plans to establish a state-of-the-art Global Capability Centre (GCC) in Visakhapatnam, Andhra Pradesh. The initiative marks a significant milestone in Eisai’s digital transformation strategy in India and aims to harness the region’s technological talent and innovation ecosystem.

This was revealed by Makoto Haketsu, Global Chief Information Officer, Eisai Pharma, who had visited GITAM (Deemed to be University) on Wednesday. He was accompanied by a high-level technical team and met Visakhapatnam Member of Parliament and GITAM President M. Sribharat, seeking directions for the academic-industry interface, specifically digital healthcare innovation.

Haketsu prioritized Eisai's dedication to spearheading digital healthcare innovation through vigorous support from the Andhra Pradesh Government and Visakhapatnam Special Economic Zone (VSEZ). "India has excellent digital human resources, and we will create next-generation healthcare technology to meet global changing needs," he further added. He also valued GITAM's research environment and inter-disciplinary capabilities as being in line with Eisai's vision of innovation.

Also Read: Biological E Secures HPV9 Vaccine Manufacturing for India and Global Tenders

Senior GITAM administration, such as Vice-Chancellor Dr. Eroll D'Souza and Pro VC Prof. Y. Goutham Rao, and other academic heads greeted the partnership possibilities. MP Sribharat highlighted GITAM's research activities in industry-driven research in areas of data science, health technology, and pharmacy innovation.

The Eisai delegation also included key leadership from India and Japan, underscoring the company’s strategic intent to build local capacity and foster meaningful collaborations. The upcoming GCC in Visakhapatnam is expected to enhance Eisai’s global operations while positioning the city as a hub for healthcare innovation and digital excellence.

© 2025 India Pharma Outlook. All Rights Reserved.